|
COPYRIGHT 2008 International Medical News Group
NEW YORK -- Increasing experience with the biologic agents in psoriatic arthritis is showing that these drugs are effective across all domains of this complex disease.
Tumor necrosis factor (TNF) inhibitors in particular have proven beneficial in the treatment of the peripheral arthritis, skin and nail disease, axial disease, dactylitis, and enthesitis associated with psoriatic arthritis (PsA). Traditional disease-modifying antirheumatic drugs such as methotrexate, in contrast, may be useful for the arthritis and skin and nail disease, hut are less effective for the other disease manifestations,...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
